Home > Insider Trading > Filing (0001181431-14-002533)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1253689	Glycomimetics Inc	GLYC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1237289	D Scott Sandell	1954 Greenspring Drive Suite 600 Timonium MD 21093		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-01-15	3,407,283	$0.00	3,994,258	No	4	C	Indirect	See Note 3
Common Stock	Acquisiton	2014-01-15	487,500	$8.00	4,481,758	No	4	P	Indirect	See Note 3
Common Stock	Acquisiton	2014-01-15	3,580,877	$0.00	3,580,877	No	4	C	Indirect	See Note 4
Common Stock	Acquisiton	2014-01-15	512,500	$8.00	4,093,377	No	4	P	Indirect	See Note 4

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Note 3
No	4	P	Indirect	See Note 3
No	4	C	Indirect	See Note 4
No	4	P	Indirect	See Note 4

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A-1 Preferred Stock	Disposition	2014-01-15	11,250,850	$0.00	3,407,283	$0.00
Common Stock	Series A-1 Preferred Stock	Disposition	2014-01-15	11,824,058	$0.00	3,580,877	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

This represents shares received upon conversion of shares of Series A-1 convertible preferred stock.
Effective immediately prior to the closing of Issuer's initial public offering of its common stock, each share of Series A-1 Preferred Stock automatically converted into approximately 0.3028 shares of the Issuer's common stock. The Series A-1 Preferred stock had no expiration date.
The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Parnters 10"), NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest.
The Reporting Person is a director of NEA 13 GP, LTD, which is the sole general partner of NEA Partners 13, L.P. ("NEA Partners 13"). NEA Partners 13 is the sole general partner of New Enterprise Associates 13, L.P. ("NEA 13"), which is the direct beneficial owner of the securitites. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securitites Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 13 shares in which the Reporting Person has no pecuniary interest.